The current obsession with clearing senescent cells misses a major piece of the puzzle: the physics of their decay. My lab’s latest data suggests that what makes a senescent cell "stubborn" isn’t just its transcriptional output—it’s a liquid-to-solid phase transition in the cytoplasm that physically shields the cell from autophagy.

We’ve seen that once p62-labeled cargo hits a certain density, it shifts from liquid-like droplets into non-dynamic, amyloid-like aggregates. At that point, the proteasome and autophagosome are effectively locked out. We’re not just looking at senescence anymore; we’re looking at intracellular vitrification. If the cytoplasm gels, the cell essentially turns into a monument to its own past. It becomes impervious to traditional senolytics because the drugs can’t reach their targets, or worse, those targets are no longer biological entities but part of a structural prison.

This helps explain why so many interventions fall flat in late-stage aging. We’ve been treating cellular senility as a signaling problem when it’s really a material science problem.

I’m looking for collaborators—biophysicists who specialize in condensate rheology and medicinal chemists interested in molecular "melt" agents—to join Project Solstice. Our goal is to find small-molecule stabilizers that keep these organelles fluid long enough for the lysosome to do its work. We need to pivot away from apoptosis-induction and toward cytoplasmic liquefaction.

Funding is predictably tight. Most agencies are hunting for biomarkers rather than the mechanics of cellular glass, but if we don't solve the biophysics of the aging cytoplasm, all the senolytics in the world will just be throwing rocks at a wall.

Is anyone else seeing this in their lines? Are we just trying to treat a solid with a liquid solution? Let’s stop chasing the transcriptome and start studying the viscosity of time. Reach out if you want to help map this transition space.